For Patients
Welcome patients and caregivers. We bring promising new therapies to patients in surrounding states. 
Read more about our presence in the southeast.
Vanderbilt-Ingram Cancer Center Affiliate Network
- Upcoming Event: ASH Review Symposium
January 10, 2008
Nashville Marriott at Vanderbilt University
The Vanderbilt-Ingram Cancer Center Affiliate Network brings clinical trials to communities. Established in 1994, the Network has evolved from an informal network of referring community physicians into an organization of hospitals and oncology practices that participate in innovative studies of emerging new treatments. The Network Affiliates serve a vital role by helping to conduct clinical research to improve the cancer care of tomorrow and to provide patients in their communities' access to these novel therapies through participation in clinical trials.
The Network is a major force in cancer research, publishing numerous manuscripts and abstracts in medical journals, and presenting results of studies at national and international meetings. The Network membership has grown to include multiple Affiliate Member Sites located throughout Tennessee, Kentucky, Florida and Virginia.
Benefits of Network Membership:
A menu of novel Phase II and Phase III protocols for the most common cancers are offered to Network Affiliates that are not otherwise available. Studies are selected carefully to ensure they are appropriate for the patient populations of the Network sites. To maintain continuity for its members, when one study closes for any given population of patients another is ready to take its place.
A centralized study management process is established and provided through a comprehensive support structure. The Network staff is experienced in data management, central contracting and study budgeting, as well as other administrative support including various regulatory activities such as IND applications, IRB submissions and SAE reporting. Ongoing clinical research training is provided for Network members, plus two annual CME oncology conferences.
Individual member institutions can select studies appropriate for their patient population. Selected studies are subsequently submitted to the Affiliate's local IRB or The Vanderbilt Central IRB, which is now available to Network Affiliates. Network members that utilize Vanderbilt's Central IRB receive the benefit of having all paperwork related to protocol submissions processed by the Network staff. Upon IRB approval, the trials are opened to accrual.
